Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 29 of 1714:
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage gated, type VIII, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type VII, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IV, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IV, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
progesterone receptor MEDROXYPROGESTERONE Progesterone 91% .711uM .093uM View
angiotensin 1 converting enzyme 1 ENALAPRIL Protease, Angiotensin Converting Enzyme 91% 3.33uM NoneNone View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ENALAPRIL Protease, Angiotensin Converting Enzyme 91% 3.33uM NoneNone View
arachidonate 15-lipoxygenase ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
arachidonate 15-lipoxygenase, second type ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
arachidonate 15-lipoxygenase ETHINYLESTRADIOL Lipoxygenase 15-LO 91% 5.678uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B ETHINYLESTRADIOL Serotonin 5-HT4 91% 7.953uM 1.326uM View
5-hydroxytryptamine (serotonin) receptor 4 ETHINYLESTRADIOL Serotonin 5-HT4 91% 7.953uM 1.326uM View
5-hydroxytryptamine (serotonin) receptor 2C TIRILAZAD Serotonin 5-HT2C 91% .718uM .376uM View
adrenergic receptor, alpha 2a AMLODIPINE Adrenergic alpha2A 91% .602uM .226uM View
calcium channel, voltage-dependent, gamma subunit 5 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 4 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
5-hydroxytryptamine (serotonin) receptor 1B HYDROXYUREA Serotonin 5-HT1B 19% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 2 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 1 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 4 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 3 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 2 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, alpha 1F subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, beta 1 subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 8 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 7 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
calcium channel, voltage-dependent, gamma subunit 6 AMITRIPTYLINE Calcium Channel Type L, Phenylalkylamine 91% .84uM .816uM View
Protein-tyrosine kinase, Fyn U-78517F Protein Tyrosine Kinase, Fyn 91% 1.649uM NoneNone View
Sigma-2 Receptor AMIODARONE Sigma2 91% .117uM .072uM View
calcium channel, voltage-dependent, gamma subunit 8 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 7 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 6 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 5 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 4 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 3 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 2 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, gamma subunit 1 CHLORPROMAZINE Calcium Channel Type L, Benzothiazepine 91% 3.214uM 2.857uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, alpha 1F subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, beta 1 subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CLOZAPINE Calcium Channel Type L, Phenylalkylamine 91% .612uM .595uM View
5-hydroxytryptamine receptor 6 CARVEDILOL Serotonin 5-HT6 91% 1.519uM .705uM View
dopamine receptor 2 CLOZAPINE Dopamine D2L 91% .387uM .129uM View
opioid receptor, sigma 1 DEXFENFLURAMINE Sigma1 91% .516uM .217uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) BENZBROMARONE CYP450-2C9 Inhibition 91% .016uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 BENZBROMARONE CYP450-2C9 Inhibition 91% .016uM NoneNone View
opioid receptor, kappa 1 BENZOTHIAZYL DISULFIDE Opiate kappa 91% 1.243uM .497uM View
progesterone receptor DESOXIMETASONE Progesterone 91% .084uM .011uM View
progesterone receptor DESOXIMETASONE Progesterone 91% .084uM .011uM View
progesterone receptor FLUNISOLIDE Progesterone 91% .359uM .047uM View
progesterone receptor FLUNISOLIDE Progesterone 91% .359uM .047uM View
5-hydroxytryptamine (serotonin) receptor 1A FLUPHENAZINE Serotonin 5-HT1A 91% 1.644uM .939uM View
adrenergic receptor, alpha 2b BENZOTHIAZYL DISULFIDE Adrenergic alpha2C 91% 1.658uM .241uM View
adrenergic receptor, alpha 2c (Non-specific probe) BENZOTHIAZYL DISULFIDE Adrenergic alpha2C 91% 1.658uM .241uM View
dopamine receptor D3 DOXEPIN Dopamine D3 91% 1.393uM .473uM View
prostaglandin-endoperoxide synthase 1 MELOXICAM Cyclooxygenase COX-1 91% 1.319uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) MELOXICAM Cyclooxygenase COX-1 91% 1.319uM NoneNone View
adrenergic receptor, alpha 2a TRAZODONE Adrenergic alpha2A 91% .909uM .341uM View
adrenergic receptor, alpha 2b TOLPERISONE Adrenergic alpha2B 91% 1uM .456uM View
adrenergic receptor, alpha 2b HALOPERIDOL Adrenergic alpha2C 91% 1.845uM .268uM View
adrenergic receptor, alpha 2c (Non-specific probe) HALOPERIDOL Adrenergic alpha2C 91% 1.845uM .268uM View
epidermal growth factor receptor GENTIAN VIOLET Protein Tyrosine Kinase, EGF Receptor 91% .473uM NoneNone View
sodium channel, voltage-gated, type IV, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel associated protein 1 VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel associated protein 2 VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type III, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type I, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IX, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type VII, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
amiloride-sensitive cation channel 5, intestinal VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type III, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type XI, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type I, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type 10, alpha polypeptide VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type IV, alpha polypeptide VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type V, alpha polypeptide VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type II, beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1 alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1 gamma VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1 beta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, voltage-gated, type XI, alpha VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1, gamma VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1, delta VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) VERAPAMIL Sodium Channel, Site 2 91% 2.005uM 1.83uM View
calcium channel, voltage-dependent, beta 4 subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, beta 3 subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, beta 2 subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
protein kinase C, theta LAMOTRIGINE Phorbol Ester 2% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, alpha 1F subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, beta 1 subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TAMOXIFEN Calcium Channel Type L, Phenylalkylamine 92% 2.042uM 1.985uM View
adrenergic receptor, beta 3 TAMOXIFEN Adrenergic beta3 92% 7.703uM 5.778uM View
calcium channel, voltage-dependent, gamma subunit 8 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 7 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 6 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 5 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 4 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 3 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 2 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 1 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, beta 4 subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, beta 3 subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, beta 2 subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, alpha 1F subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, beta 1 subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CISAPRIDE Calcium Channel Type L, Phenylalkylamine 92% .53uM .515uM View
calcium channel, voltage-dependent, gamma subunit 3 DICYCLOMINE Calcium Channel Type L, Phenylalkylamine 92% .11uM .107uM View
calcium channel, voltage-dependent, gamma subunit 2 DICYCLOMINE Calcium Channel Type L, Phenylalkylamine 92% .11uM .107uM View
glycine receptor, alpha 1 subunit IVERMECTIN Glycine, Strychnine-Sensitive 92% .3747uM .2118uM View
glycine receptor, beta subunit IVERMECTIN Glycine, Strychnine-Sensitive 92% .3747uM .2118uM View
glycine receptor, alpha 2 subunit IVERMECTIN Glycine, Strychnine-Sensitive 92% .3747uM .2118uM View
cholinergic receptor, muscarinic 5 IVERMECTIN Muscarinic M5 92% 3.608uM 2.5922uM View
Cytochrom P450-2D6 monooxygenase LISURIDE CYP450-2D6 Inhibition 92% .016uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 ERGOTAMINE CYP450-3A4 Inhibition 92% 1uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 7 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 6 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 5 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 4 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 3 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 2 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, gamma subunit 1 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, beta 4 subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, beta 3 subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, beta 2 subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, alpha 1F subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, beta 1 subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PROMAZINE Calcium Channel Type L, Phenylalkylamine 92% 1.193uM 1.16uM View
dopamine receptor D3 QUETIAPINE Dopamine D3 92% 1.1632uM .3951uM View
adrenergic receptor, alpha 1a EPINEPHRINE Adrenergic alpha1A 92% .628uM .254uM View
opioid receptor, sigma 1 TERCONAZOLE Sigma1 92% .508uM .214uM View
5-hydroxytryptamine (serotonin) receptor 1A SUMATRIPTAN Serotonin 5-HT1A 92% .804uM .459uM View
cholinergic receptor, muscarinic 2 PAROXETINE Muscarinic M2 92% .532uM .189uM View
adrenergic receptor, alpha 2b CYPROHEPTADINE Adrenergic alpha2C 92% 1.275uM .185uM View
adrenergic receptor, alpha 2c (Non-specific probe) CYPROHEPTADINE Adrenergic alpha2C 92% 1.275uM .185uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 PIPAMAZINE Serotonin Transporter 92% .651uM .346uM View
adrenergic receptor, alpha 2a ECONAZOLE Adrenergic alpha2A 92% 4.325uM 1.622uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 ECONAZOLE CYP450-3A4 Inhibition 92% .05uM NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, beta 1 subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 8 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 7 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 6 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 5 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 4 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 3 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 2 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, gamma subunit 1 MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, beta 4 subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, beta 3 subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, beta 2 subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MICONAZOLE Calcium Channel Type L, Dihydropyridine 92% 6.266uM 4.028uM View
ATPase, Na+/K+ transporting, alpha 4 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide OUABAIN ATPase, Na+/K+ 92% .678uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View
calcium channel, voltage-dependent, gamma subunit 4 THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View
calcium channel, voltage-dependent, gamma subunit 3 THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View
calcium channel, voltage-dependent, gamma subunit 2 THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View
calcium channel, voltage-dependent, gamma subunit 1 THIORIDAZINE Calcium Channel Type L, Benzothiazepine 91% .469uM .417uM View